Eplebless 50mg Tablet contains Eplerenone 50mg, a selective aldosterone receptor antagonist used primarily in the management of hypertension and heart failure. By competitively blocking aldosterone receptors in the distal renal tubules, Eplerenone promotes sodium and water excretion while conserving potassium, thereby reducing blood volume and lowering blood pressure. It is indicated for patients with essential hypertension and for reducing cardiovascular morbidity and mortality in patients with left ventricular dysfunction following myocardial infarction. Eplebless is contraindicated in patients with hyperkalemia, severe renal impairment, or hypersensitivity to eplerenone or any excipients. Caution is advised when used concomitantly with potassium-sparing diuretics, potassium supplements, or other agents that increase serum potassium levels due to the risk of hyperkalemia. Regular monitoring of serum potassium and renal function is recommended during therapy. Eplebless should be administered once daily, with or without food, as directed by a healthcare professional. Common adverse effects may include dizziness, hyperkalemia, and gastrointestinal disturbances. Patients are advised to report symptoms such as muscle weakness or irregular heartbeat promptly. Eplebless 50mg Tablet offers a targeted approach to managing cardiovascular conditions by modulating aldosterone activity, contributing to improved clinical outcomes.